骨髓發生 的英文怎麼說

中文拼音 [gǔsuǐfāshēng]
骨髓發生 英文
myelogenesis
  • 骨 : 骨名詞1 （骨頭） bone2 （物體內部的支架） framework; skeleton 3 （品質; 氣概） character; spirit ...
  • 髓 : 名詞1. [生理學] （骨髓; 像骨髓的東西） marrow 2. [植物] （莖的中心部分） pith
  • 發 : 名詞（頭發） hair
  • 生 : Ⅰ動詞1 （生育; 生殖） give birth to; bear 2 （出生） be born 3 （生長） grow 4 （生存; 活） live;...
  • 骨髓 : marrow; keest; medulla ossium; bone marrow骨髓白細胞 myeloplast; 骨髓病 myelopathy; myelopthy; os...
  1. Adequate preoperative fluid hydration, intensive hemodynamic monitoring, ready - prepared blood and vasopressor drugs, inspiration of 100 percent oxygen, and copious irrigation of marrow debris after reaming are useful prophylactic methods to lower the catastrophic complication during cementation

    足夠的術前水分補給，手術中精細的生命徵象監視，隨時準備好的血液及增壓藥物以備不時之需，呼吸純氧以預防低血氧癥，在骨髓腔管被擴鉆后使用大量的水清洗骨髓腔管內的雜質，這些是降低骨水泥心臟血管衰竭並發癥發生的有效方法。
  2. Deficiency of apoe may promote to produce and develop atherosclerotic lessions. the apoe gene - targeted mice will result in marked regression of both early and advanced atherosclerotic lesions by injected apoe recombinant protein, or by transfected adviral vector with apoe cdna to express human apoe transgene in liver, or by transplantation of bone marrow with normal rat apoe gene. this demonstrates that apoe gene and its expressing product can inhibit progression of atherogenesis. apoe3 has a more effective prevention from as than apoe2 and apoe4

    Apoe的缺失可促進動脈粥樣硬化的發生發展，給apoe基因敲除鼠反復注射apoe重組蛋白、在肝組織中用腺病毒載體表達apoe蛋白、移植帶有正常apoe基因的小鼠骨髓，都能使apoe基因敲除鼠的動脈粥樣硬化得到回復，表明apoe基因及其表達產物對動脈粥樣硬化的發生具有抑制作用， apoe _ 3對動脈硬化的阻抑作用要比apoe _ 2和apoe _ 4都明顯。
  3. In this report, we mainly covered the following aspects of " tissue organ regeneration and replication in situ " : 1 ) procedures of tissue organd regeneration and replication and replication in clnical practice ; 2 ) the discover and existence of potentiald regenerative cell ( prc ) ; 3 ) the proliferation, differentiation and regeneration law of potential law of potential regenerative cells ; 4 ) study procedure on tissue organ regeneration and replication from prcs in vitro based on the model of full skin organ regeneration in situ after extensive in vitro, set up the method and technology of searching life regenerative substance required in tissue organ regeneration and replication in situ. in this study, first, the whole human body is divided into 206 function units, which are the " tissue organ " in regeneration study. then the histology foundation of tissue organ regeneration and replication in situ is set up. in ordre to prove the existence of the potential regenerative cells and their potential baility and function, we established clinical tracking rechnique of skin organ regeneration in situ ; meanwhile, several tissue organ regeneration and replication in vitro models which represent different kinds of runctions were sucessfully set up, with all these techniques and models, we confirmed : 1 ) the existence, function and ability of pptemtoa regenerative cells ; 2 ) the importance of life regenerative substance ; 3 ) the feasibility of tissue organ regeneration and replication in situ ; 4 ) the big value of tissue organ regeneration and replication in situ in life science and medicine progerss. we also showed the possible foreground of capture cancer with this method and technologh. in this report, nearly 200 photographs of several tissue organ regeneration and replication in situ or in vitro demonstrated the whole process of tissue organ and big organ entities regeneration and replication from cells. the results of tissue organ regeneration and replication in situ mainly include : 1 ) whole skin organ regeneration and replication in situ ; 2 ) gastrointestinal mucosa tissue organ regeneration in vitro ; 3 ) hair follicle tissue organ regeneration in situ or in vitro ; 4 ) never tissue organ regeneration in situ ; 5 ) pancreas tissue organ regeneration and replication in vitro ; 5 ) marrow tissue regeneration in vitro ; 6 ) renal glomerulus and tubule tissue organ tugeneraation in vitro ; 7 ) heart muscle regeneration in vitro, etcl. in order to let more and more people know and understand this technology of tissue organd regeneration and replication in situ, herein, for the first time, we publicize the key points of actualizing this technology. also, we publicized the technology procedures and the frame constitute of life substances. we bilieve this is a big contribution to human science

    本研究報告，重點報道了組織器官的原位再生復制的臨床程序，報道了組織潛能再生細胞的發現和存在，以及該細胞的增殖分化和形成組織器官的變化規律.以燒傷后皮膚組織器官的原位再生復制為模型，研究出了體外組織潛能再生細胞復制組織器官的培養方法;以體外組織器官的復制為模型，建立了尋找原位組織器官再生復制所需生命物質的方法和技術.本研究，首先按人體的器官功能，分解為206個功能單位，確立了所復制的人體器官中的組織功能單位為組織器官，從而建立了原位組織器官再生復制的組織學基礎.為了驗證組織潛能再生細胞的再生潛能，建立了皮膚器官原位再生的實體臨床跟蹤技術，同時又建立了能代表有關器官功能類別的代表組織器官的原位和體外復制模型，以多組織器官的成功復制確定潛能再生細胞的作用，確定生命研究再生物質的重要性，確定組織器官原位再生復制的可行性，確定了組織器官原位再生復制的生命科學研究和醫學進步的重大應用價值，同時展示了用此方法和技術攻克癌癥的前景.本研究報告，以近二百幅多個組織器官原位和體外再生復制的實體圖片，展示了潛能再生細胞復制的組織器官和大器官司實體;展示了細胞再生復制器官的全過程.真實的報告了組織器官原位再生復制的成果.所公布的主要成果為:皮膚器官的原位再生復制;胃腸黏膜組織器官的原位和體外再生復制;毛囊組織器官的原位和體外再生復制;神經組織器官的原位復制;胰腺組織器官的體外復制;骨髓組織的體外復制;腎小球小管組織器官的體外復制;心肌的體外復制等.為了讓更多的人學會和掌握組織器官原位再生復制技術，本報告首次公布實施技術的重要環節和技術流程;首次公布了生命再生物質的框架和組成.作者自費研究成果對人類生命科學的一大貢獻
  4. This gs case is unusual because of the disease happened after 12 years of aml remission in a patient considered to have been in remission of acute myelogenous leukemia ( aml ) for twelve years

    本病例曾患急性骨髓性白血病，並經治療且疾病緩解十二年後，在子宮頸上發生顆粒性白血球肉瘤，因此更顯此病例特殊之處。
  5. We report four new cases of zygomycosis in transplant recipients illustrating the large clinical spectrum of this infection : one disseminated infection with heart involvement and one rhinocerebral infection with dissemination in two bone marrow transplant recipients, one cutaneous infection in a liver and one pulmonary infection in a kidney recipient

    我們在此報道4例移植受者的接合菌病說明該感染在臨床上波及較廣： 2例骨髓移植中1例發生累及心臟的廣泛感染、另1例鼻顱腔廣泛感染， 1例肝移植患者皮膚感染， 1例腎移植患者肺部感染。
  6. As a proteasome inhibitor, bortezomib has shown inhibition on cell proliferation, inducing cell apoptosis, inhibition of cell adhension and inhibition of tumor angiogenesis for multiple myeloma cells

    摘要硼替佐米作為一種蛋白酶抑制劑，對多發性骨髓瘤細胞表現出抑制細胞生長、誘導腫瘤細胞凋亡、抑制細胞粘附、抑制腫瘤血管生成等作用，同時對血液系統其他惡性腫瘤具有顯著的作用。
  7. The red blood cells of a normal person, for instance, age and die in 120 days. new blood cells are formed in bone marrow cells to ensure normal functioning of the human body. however, a vitamin b12 deficiency can make the red blood cells dysfunctional or prevent their successful formation, which in turn causes megaloblastic anemia anemia in which abnormally sized red blood cells are found in the blood. in some cases, prolonged vitamin b12 deficiency can deter the formation and functioning of myelin, subsequently leading to neuritis inflammation of the nerves or incomplete brain development

    例如，人類正常的紅血球每120天便會老化死亡，所以骨髓細胞會持續產生新的紅血球，以維持人類正常之身體功能，所以如果缺乏維他命b12 ，便容易造成紅血球生合成功能不全，進而導致巨大型紅血球貧血megaloblastic anemia又例如，因長期缺乏維他命b12 ，會造成神經髓鞘myelin生合成功能不全，進而導致神經炎及腦部發育不全等等。
  8. Treatment of avascular necrosis of femoral head by implanting a composite of bone marrow, bone morphogenetic protein, and noncelluar tissue engineered bone allograft

    非細胞型組織工程化異體骨復合骨形態發生蛋白和紅骨髓治療股骨頭缺血性壞死
  9. Several studies have shown that so2 and its derivatives could induce chromosomal aberrations, sister chromatid exchanges and micronuclei in human blood lymphocyte, bone marrow cell in mice and chl

    研究發現， so _ 2及其衍生物可引起人外周血淋巴細胞、小鼠骨髓細胞、中國倉鼠肺成纖維細胞等哺乳動物細胞的染色體畸變、姊妹染色單體交換及微核的形成。
  10. All the complications happened in either the patients receiving cemented intramedullary nail for pathological femoral fracture or cemented bipolar hemiarthroplasty for hip fracture

    所有的這些心臟血管衰竭並發癥發生在病理性股骨骨折接受骨水泥骨髓腔內鋼釘的病人，或股骨頸骨折接受骨水泥兩極式人工股骨頭置換術的病人。
  11. The timing of onset of cardiovascular collapse most occurred immediately after impacting the implant into a cemented canal, but it might delay ten minutes as in our cases

    在我們的報告中，發生心臟血管衰竭並發癥的時間大部分是在將骨內鋼釘或兩極式人工股骨頭打入灌有骨水泥的骨髓腔后馬上發生，但可延遲到十分鐘后才發生。
  12. To treat the complication, adequate antibiotics and surgical intervention should be performed at the same time

    為了治療這額骨骨髓炎的並發癥，正確的抗生素及適當的手術處理是必須同時進行的。
  13. Through her tears, kristi repeated the diagnosis, " michael has my elodysplastic syndrome. it ' s a pre - leukemia disease. he needs a bone - marrow transplant.

    克麗絲蒂嗚咽地重復著醫生的診斷： 「邁克爾得了骨髓發育不良綜合癥，那是白血病前期… …他得接受骨髓移植。 」
  14. Bone marrow stem cells can switch roles to produce a protein that promotes growth of the cornea, the transparent layer of the eyeball, scientists have found

    科學家已經發現骨髓幹細胞能夠轉化角色，產生一種蛋白。該蛋白能促進眼角膜（眼球透明層）的生長。
  15. One day an infant born with a genetic defect of the bone marrow or blood may be able to have his umbilical cord blood harvested at birth, repaired by genetic engineering and then reinfused, so that he need never suffer the negative effects of his genetic inheritance

    有朝一日，骨髓或血液發生遺傳缺失的嬰兒，都可用出生時收集的臍帶血，以基因工程修復后再輸回體內；這樣一來，他一輩子都不必為遺傳疾病所苦。
  16. A related blood disorder, myelodysplastic syndromes, or mds, occurs when the bone marrow begins producing poorly functioning or immature blood cells. about 20, 000 to 30, 000 new cases occur each year

    骨髓增生異常綜合癥（ mds ）也是一種血液相關的疾病，是由於骨髓產生非成熟或無功能的血細胞。美國每年新發病例大約為20000 - 30000 。
  17. Methods : isolated rabbit bmsc by adhesion method and cultured it at 37c, 5 % co2 incubator. graphic the growth curve after observed the growth of primary cells and passage cells. cultured bmsc in calcified solution and observe its potential of osteogenic

    方法：貼壁法分離第四軍醫大學碩士學位論文兔骨髓基質幹細胞， 37 ， 5 % co :培養箱培養，觀察原代及傳代細胞的生長發育情況，並繪制生長曲線;在礦化液中連續培養，觀察其骨形成能力。
  18. Expression in bone marrow mesenchymal cells transfected by bone morphogenetic protein 7 gene recombination and its significance

    重組骨形態發生蛋白7基因轉染骨髓間充質幹細胞及其在該細胞中的表達
  19. So in our experiment, we applied with freezing and drying bone and bone marrow stem cells ( bmsc ) as cellular seeds. in these conditions, freezing and drying bones provided fine interspaces structure and good adhesive and grow conditions. at the same time, bmsc which transfected vascular endothelial growth factors ( vegf ) as cellular seeds provided the seeds and stimulating factors

    目前，深凍骨已商品化，免疫排斥反應罕見發生，故本實驗以凍干松質骨作為基質材料、轉染有血管內皮細胞生長因子（ vegf ）的骨髓基質幹細胞（ bmsc ）為種子細胞，這樣既保持了骨組織優良的空間結構，又提供了種子細胞和血管化的刺激因子。
  20. The hfea says that it has yet to face a situation where it is asked to reveal the identity of a donor because a di child has a genetic condition or a disease such as leukaemia where bone marrow from a biological father might be needed to save a child ' s life

    Hfea說，該機構還要面臨一種情況：如果人工授精孩子患有遺傳病或白血病這類疾病，他她可能需要生父的骨髓才能活命。 hfea一位發言人說： 「但是，目前的法律非常明確。捐獻者的身份必須保密。 」
分享友人
分享到 Line

分享到臉書